Deirdre Gillespie Insider Profile
4 Followers
Deirdre Gillespie, Director at Seelos Therapeutics, holds 15.43K shares in Seelos Therapeutics (Ticker: SEELQ), holds 0.00 shares in La Jolla Pharma (Ticker: LJPC).
Deirdre Gillespie's Trading History
| SEELQSeelos Therapeutics | Jan 04, 2012 | Director | Uninformative Buy | 14.28K | ― | |
| LJPCLa Jolla Pharma | May 18, 2011 | ― | Informative Sell | 991.66 | $0.00 |
You May Also Like
Deirdre Gillespie insider profile FAQ
What is the percentage of profitable transactions made by Deirdre Gillespie?
The percentage of profitable transactions made by Deirdre Gillespie is 100%.
What is the average return per transaction made by Deirdre Gillespie?
The average return per transaction made by Deirdre Gillespie is 98.00%.
What stocks does Deirdre Gillespie hold?
Deirdre Gillespie holds: SEELQ, LJPC stocks.
What was Deirdre Gillespie’s latest transaction?
Deirdre Gillespie’s latest transaction was an Uninformative Buy of $14.28K.
What was Deirdre Gillespie's most profitable transaction?
Deirdre Gillespie’s most profitable transaction was an Informative Sell of LJPC stock on April 20, 2011. The return on the trade was 99.90%.
What is Deirdre Gillespie's role in Seelos Therapeutics?
Deirdre Gillespie's role in Seelos Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
